» Articles » PMID: 39119550

Freeze-drying Protocols and Methods of Maintaining the In-vitro Biological Activity of Horse Platelet Lysate

Overview
Date 2024 Aug 9
PMID 39119550
Authors
Affiliations
Soon will be listed here.
Abstract

Platelet lysate, derived from platelets, are valuable biological products rich in bioactive molecules. Their use promotes tissue healing and modulates inflammation. However, maintaining the stability and bioactivity of platelet lysate is challenging since they degrade rapidly at room temperature. This study focused on the possibility to confer enhanced stability to freeze-dried equine platelet lysate as an alternative to platelet-rich plasma (PRP). Platelet lysate (PL) was derived from PRP and freeze-dried either as such or using various adjuvants. Primary cell cultures of porcine Vascular Wall-Mesenchymal Stem Cells were treated with different PL formulations, and cell viability was assessed using an MTT assay. Overall, the addition of PL significantly improved cell viability as compared to controls without growth factor supplementation or with foetal bovine serum. Notably, the freeze-drying process maintained the effectiveness of the PL for at least a week. Furthermore, the study revealed that varying the horse as the source of PL could yield varying effects on cell viability. Detailed freeze-drying protocols were established, including freezing, primary drying and secondary drying phases, and the type of adjuvant. This study demonstrated the potential of freeze-dried equine PL as a viable alternative to PRP and highlighted the importance of precise freeze-drying protocols and adjuvants for standardization. Equine PL showed promise for medical treatment in horses, offering advantages such as extended shelf life, ease of handling, and reduced transportation costs, with the potential for broadened therapeutic usage.

References
1.
Beech K, Biddlecombe J, van der Walle C, Stevens L, Rigby S, Burley J . Insights into the influence of the cooling profile on the reconstitution times of amorphous lyophilized protein formulations. Eur J Pharm Biopharm. 2015; 96:247-54. DOI: 10.1016/j.ejpb.2015.07.029. View

2.
Zhang S, Qian H, Wang Z, Fan J, Zhou Q, Chen G . Preliminary study on the freeze-drying of human bone marrow-derived mesenchymal stem cells. J Zhejiang Univ Sci B. 2010; 11(11):889-94. PMC: 2970899. DOI: 10.1631/jzus.B1000184. View

3.
Dohan Ehrenfest D, Rasmusson L, Albrektsson T . Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009; 27(3):158-67. DOI: 10.1016/j.tibtech.2008.11.009. View

4.
Crowe J, Tablin F, Wolkers W, Gousset K, Tsvetkova N, Ricker J . Stabilization of membranes in human platelets freeze-dried with trehalose. Chem Phys Lipids. 2003; 122(1-2):41-52. DOI: 10.1016/s0009-3084(02)00177-9. View

5.
Garbin L, Olver C . Platelet-Rich Products and Their Application to Osteoarthritis. J Equine Vet Sci. 2020; 86:102820. DOI: 10.1016/j.jevs.2019.102820. View